Wittington Ventures·Sep 24Canadian Science, Global Ambition: Meet our First Weston Breakthrough FellowsCanada produces world-leading climate science with the potential for significant real-world impact. What is too often missing is the early…
Wittington Ventures·Jun 17From Lab to Market: Introducing Weston Breakthrough FellowsCanada produces some of the world’s most important research. Our universities are globally ranked. Our scientists publish discoveries that…
Wittington Ventures·Jun 2Why We Invested in Filament SciencesEvery so often, a category resets and opens a window to back the next defining brand. We think that’s exactly what’s happening in…
Wittington Ventures·Apr 20Building the Computational Layer for Biomarker Discovery: Our Investment in ViewsMLAt Wittington Ventures, we’re drawn to moments where advances in science outpace the tools used to measure them. In healthcare, one of the…
Wittington Ventures·Mar 24Investing in Doctronic: AI and the Clinical Access LayerEvery industry develops systems that determine how demand is sorted, routed, and resolved. In finance, payment networks structure how…
Wittington Ventures·Feb 17Why We Invested in Shakudo: The Operating System for Secure Enterprise AIAt Wittington Ventures, our mandate is to back platforms that drive real transformation for essential industries through next-gen…
Wittington Ventures·Nov 19, 2025Digitizing Care Transitions: Why We Led WellBeam’s Series AAt Wittington Ventures, we invest in technologies that make essential industries smarter, faster, and more connected. Healthcare is one of…
Wittington Ventures·Aug 29, 2024Revolutionizing Cancer Immunotherapy with AI: Wittington Ventures’ Investment in NoetikAt Wittington Ventures, we believe artificial intelligence will revolutionize healthcare — we have already started to see it through our…
Wittington Ventures·Apr 15, 2024The WV Edge: How Wittington Ventures Fuels Growth for StartupsSetting the Stage for Startup Success
Wittington Ventures·May 1, 2023Revolutionizing Pharma Sales Enablement with AI: Our Investment in Odaia.In 2021, the top seven pharmaceutical companies spent a staggering $103B on sales and marketing, 37% more than they did on R&D for new…